Mukhopadhyay A, Manna S K, Aggarwal B B
Cytokine Research Laboratory, Department of Bioimmunotherapy, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
J Biol Chem. 2000 Mar 24;275(12):8549-55. doi: 10.1074/jbc.275.12.8549.
Tumor necrosis factor activates nuclear transcription factor kappaB (NF-kappaB) by inducing serine phosphorylation of the inhibitory subunit of NF-kappaB (IkappaBalpha), which leads to its ubiquitination and degradation. In contrast, pervanadate (PV) activates NF-kappaB and induces tyrosine phosphorylation of IkappaBalpha (Singh, S., Darney, B. G., and Aggarwal, B. B. (1996) J. Biol. Chem. 271, 31049-31054; Imbert, V., Rupec, R. A., Antonia, L., Pahl, H. L., Traenckner, E. B.-M., Mueller-Dieckmann, C., Farahifar, D., Rossi, B., Auderger, P., Baeuerle, P. A., and Peyron, J.-F. (1996) Cell 86, 787-798). Whether PV also induces IkappaBalpha degradation and whether degradation is required for NF-kappaB activation are not understood. We investigated the effect of PV-induced tyrosine phosphorylation on IkappaBalpha degradation and NF-kappaB activation. PV activated NF-kappaB, as determined by DNA binding, NF-kappaB-dependent reporter gene expression, and phosphorylation and degradation of IkappaBalpha. Maximum degradation of IkappaBalpha occurred at 180 min, followed by NF-kappaB-dependent IkappaBalpha resynthesis. N-Acetylleucylleucylnorlucinal, a proteasome inhibitor, blocked both IkappaBalpha degradation and NF-kappaB activation, suggesting that the IkappaBalpha degradation is required for NF-kappaB activation. PV did not induce serine phosphorylation of IkappaBalpha but induced phosphorylation at tyrosine residue 42. Unlike tumor necrosis factor (TNF), PV did not induce ubiquitination of IkappaBalpha. Like TNF, however, PV induced phosphorylation and degradation of IkappaBalpha, and subsequent NF-kappaB activation, which could be blocked by N-tosyl-L-phenylalanine chloromethyl ketone, calpeptin, and pyrrolidine dithiocarbomate, suggesting a close link between PV-induced NF-kappaB activation and IkappaBalpha degradation. Overall, our studies demonstrate that PV activates NF-kappaB, which, unlike TNF, requires tyrosine phosphorylation of IkappaBalpha and its degradation.
肿瘤坏死因子通过诱导核转录因子κB(NF-κB)抑制亚基(IκBα)的丝氨酸磷酸化来激活NF-κB,这导致其泛素化和降解。相比之下,过钒酸钠(PV)激活NF-κB并诱导IκBα的酪氨酸磷酸化(辛格,S.,达尼,B.G.,和阿加瓦尔,B.B.(1996年)《生物化学杂志》271卷,31049 - 31054页;安贝尔特,V.,鲁佩克,R.A.,安东尼娅,L.,帕尔,H.L.,特伦克纳,E.B.-M.,米勒 - 迪克曼,C.,法拉希法尔,D.,罗西,B.,奥德格,P.,拜厄勒,P.A.,和佩龙,J.-F.(1996年)《细胞》86卷,787 - 798页)。PV是否也诱导IκBα降解以及降解对于NF-κB激活是否必需尚不清楚。我们研究了PV诱导的酪氨酸磷酸化对IκBα降解和NF-κB激活的影响。通过DNA结合、NF-κB依赖的报告基因表达以及IκBα的磷酸化和降解确定,PV激活了NF-κB。IκBα的最大降解发生在180分钟,随后是NF-κB依赖的IκBα再合成。蛋白酶体抑制剂N-乙酰亮氨酰亮氨酰缬氨醛阻断了IκBα降解和NF-κB激活,表明IκBα降解是NF-κB激活所必需的。PV未诱导IκBα的丝氨酸磷酸化,但诱导了酪氨酸残基42处的磷酸化。与肿瘤坏死因子(TNF)不同,PV未诱导IκBα的泛素化。然而,与TNF一样,PV诱导了IκBα的磷酸化和降解以及随后的NF-κB激活,这可被N-对甲苯磺酰-L-苯丙氨酸氯甲基酮、钙蛋白酶抑制剂和吡咯烷二硫代氨基甲酸盐阻断,表明PV诱导的NF-κB激活与IκBα降解之间存在密切联系。总体而言,我们的研究表明PV激活NF-κB,与TNF不同,它需要IκBα的酪氨酸磷酸化及其降解。